Keraplast Manufacturing

What Keraplast Manufacturing does

Keraplast Manufacturing is a New Zealand-based biotechnology company that develops and manufactures functional keratin ingredients and wound care biomaterials from regeneratively farmed New Zealand sheep's wool. Its proprietary Functional Keratin® technology platform uses a mild extraction process that preserves bioactivity and cystine content, enabling production of three distinct keratin ingredient types — intermediate filament protein (IFP), oxidised keratin, and hydrolysed keratin — that are 91% homologous to human keratin. The portfolio comprises branded ingredients for topical personal care (Cynergy TK, FK Repair Ultra, FK Scalp, FK Restore, FK Protect Plus, CoreTX-pep), ingestible nutraceuticals (keraGEN-IV), and MedTech wound care products (Keramatrix, Keragel, Kerox). The intellectual property base includes 28 patents with an international portfolio of over 130 patents across 36 patent families.

The company operates a B2B ingredient supplier model, selling branded keratin ingredients directly to global personal care, nutraceutical, and wound care manufacturers and through distribution partnerships with Croda International, AIDP Inc, IFF Health, and CDL Union (Asia). Named enterprise customers include Nutrafol, UniAsia, OMI Wellbeauty, Nutrilinq, NOOR, Barimelts, Dog Years, and BioWound Solutions, spanning nutraceutical, haircare, skincare, pet wellness, and wound care end-markets across 22 countries. Pricing is negotiated through direct commercial engagement, with no public consumer-facing pricing disclosed.

Manufacturing is centred at the company's headquarters and production facility at 520 Waterloo Road, Islington, Christchurch, New Zealand, supported by a five-year exclusive supply contract with Wools of New Zealand covering 400 tonnes of super-premium regenerative wool from approximately 30 certified growers at a ~40% premium over market. The company is a wholly owned subsidiary of Keraplast Technologies LLC, with 11-50 employees. Notable milestones include the August 2025 first shipment of Keramatrix, the October 2025 exclusive US manufacturing partnership with BioWound Solutions, and the implementation of a four-day working week — claimed as the first by any manufacturing company globally.

Name

Keraplast Manufacturing

Legal name

Keraplast Manufacturing

Website

https://keraplast.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Keraplast Manufacturing is a New Zealand-based biotechnology company that produces proprietary soluble, bioactive keratin ingredients and wound care biomaterials from regeneratively farmed sheep's wool for personal care, nutraceutical, and MedTech manufacturers globally.

Ownership category

akta.pro rank

Product category

Functional Keratin Ingredients (Biotechnology Manufacturing)

NAICS

Food Manufacturing (311)

SIC

Food And Kindred Products (2000)

akta.pro industry

PRIMARYCRABABAF

Texturizers & Chemical Services (Relaxers, Perms, Keratin)

Consumer Products & Retail/Beauty & Personal Care/Haircare

SECONDARYCRADAOAD

Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/CPG Ingredients, Flavorings & Additives Brands

Keywords

• Functional keratin ingredients
• Personal care ingredients
• Nutraceutical keratin supplements
• Wound care biomaterials
• Wool-derived protein manufacturing

Headquarters

HQ city

Christchurch

HQ country

New Zealand

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Branded Ingredient Sales to Manufacturers: Keraplast manufactures and sells branded functional keratin ingredient blends to personal care, nutraceutical, and wound care product manufacturers globally. Revenue is generated through supply contracts with ingredient buyers (formulators, brands, distributors). The company serves as a B2B supplier, providing bioactive keratin proteins (keraGEN-IV, Cynergy TK, FK Repair Ultra, FK Scalp, FK Restore, FK Protect Plus, CoreTX-pep) to manufacturers who incorporate them into finished consumer products.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Keraplast Manufacturing produces branded Functional Keratin® ingredients — soluble, bioactive keratin proteins and peptides — from 100% regeneratively sourced New Zealand sheep's wool using a proprietary extraction process that preserves cystine content and bioactivity. The company supplies these keratin ingredients as B2B inputs to personal care manufacturers (hair care, skin care, scalp care), nutraceutical/beauty-from-within supplement brands (keraGEN-IV®), and MedTech/wound care companies (Keramatrix®, Keragel®, Kerox®). All output is sold as a finished branded ingredient to manufacturers and formulators worldwide, with 28 patents backing the underlying technology.

Product overview

Keraplast Manufacturing is a New Zealand-based biotechnology company that manufactures high-performance keratin ingredients from regeneratively farmed sheep's wool. The product portfolio consists of two main segments: (1) Branded Functional Keratin® ingredients for personal care (topical) and nutraceutical (ingestible) applications, including Cynergy TK™, FK Repair Ultra™, FK Scalp™, FK Restore™, FK Protect Plus™, CoreTX-pep™ for personal care, and keraGEN-IV® for inner beauty/beauty-from-within supplements; and (2) MedTech wound care products including Keramatrix®, Keragel®, and Kerox® manufactured under exclusive partnership with BioWound Solutions. The company operates a proprietary Functional Keratin® technology platform that produces soluble, bioactive keratin proteins that are 91% homologous to human keratin.

Differentiator

Problem solved

Functional benefit

Products and services

• keraGEN-IV®

Quantifiable outcome

• 43.1% reduction in hair fall (gold-standard clinical trial, November 2022)
• +13 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Eleven partnerships are on record, tiered core, emerging, significant and supporting.

• BioWound SolutionscoreOEM/ Whitelabel/ Licensing Partner · 1 October 2025BioWound Solutions (Las Vegas, Nevada) entered an exclusive manufacturing agreement with Keraplast for keratin-based wound care products Keramatrix®, Keragel®, and Kerox® for the US market. Keraplast manufactures using its proprietary Replicine™ keratin technology. The partnership aims to provide clinicians and healthcare providers with advanced wound management therapies that accelerate healing and improve patient outcomes.
• Dog YearsemergingChannel Partner/ Reseller/ Distributor · 1 July 2025Dog Years launched 'Skin & Coat', the first petcare supplement featuring keraGEN-IV as the key active ingredient. The product provides bioactive, functional, and soluble keratin to nourish skin and fur from within, representing Keraplast's expansion into the pet wellness market.
• UniAsiasignificantChannel Partner/ Reseller/ Distributor · 1 April 2025UniAsia's See Young Pro premium haircare line was launched in Beijing, featuring Keraplast's functionalised keratin ingredients for advanced hair restoration and protection. Keraplast's Commercial Director Scott Haycock attended the launch event, representing the partnership as a showcase of science-backed premium haircare.
• Wools of New Zealand (WONZ)coreStrategic or Co-development Partner · 1 January 2025A five-year super-premium wool supply contract between Wools of New Zealand and Keraplast delivers regeneratively farmed strong wool to Keraplast for keratin biomaterial production. For FY2025-26, the contract sets a price of $6.88/kg clean (~40% premium over market), covering 400 tonnes from ~30 certified regenerative NZ growers. WONZ CEO John McWhirter sees this as a vote of confidence in NZ wool's future, linking growers directly to high-value end uses.
• NutrafolcoreChannel Partner/ Reseller/ DistributorNutrafol, a major hair supplement brand, uses Keraplast's keraGEN-IV functional keratin as its primary active ingredient supplier for hair health supplements. Keraplast is positioning to expand this relationship and other Asia-focused hair supplement partnerships across China, South Korea, Japan, Malaysia, and Indonesia.
• CDL UnionsignificantChannel Partner/ Reseller/ DistributorCDL Union is Keraplast's key distribution partner in Asia. Discussions between Scott Haycock and CDL Union focused on strengthening collaboration to ensure continued success of distributing Keraplast's keratin ingredients across key Asian markets including China.
• Croda InternationalsignificantChannel Partner/ Reseller/ DistributorCroda International is a global ingredients company and long-standing distribution partner for Keraplast's keratin ingredients, enabling broad international reach across multiple markets and product categories.
• AIDP IncsignificantChannel Partner/ Reseller/ DistributorAIDP Inc is a global ingredient distributor and long-standing partner for Keraplast, distributing keraGEN-IV and other keratin ingredients to manufacturers in the nutraceutical and functional food space.
• IFF HealthsignificantChannel Partner/ Reseller/ DistributorIFF Health is a global health ingredient provider and established distribution partner enabling Keraplast's global reach in beauty-from-within and wellness supplement markets.
• AgResearchsupportingStrategic or Co-development PartnerAgResearch is New Zealand's largest agricultural research organisation and a key research collaborator for Keraplast's R&D programmes, supporting the science behind functional keratin technology.
• Callaghan InnovationsupportingStrategic or Co-development PartnerCallaghan Innovation is New Zealand's Innovation Agency and a research partner supporting Keraplast's ongoing R&D programmes in biomaterials, bioprocessing, and sustainable keratin innovation.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Croda International: Global specialty ingredients incumbent serving personal care, nutraceutical, and pharma with a broad portfolio. Already a Keraplast distribution partner, and a benchmark incumbent in the same end-markets.
• DSM-Firmenich: DSM-Firmenich combines nutrition/health ingredients (vitamins, proteins, nutraceutical actives) with personal care specialties. Overlaps with Keraplast in both nutraceutical actives and personal care bioactives at much greater scale.
• Evonik (Care Solutions): Evonik's Care Solutions division supplies specialty actives, proteins, and silicones to personal care and nutraceutical customers globally. A broad incumbent with overlapping protein/biotech ingredient capabilities.

Direct peers

• Givaudan Active Beauty: Givaudan's Active Beauty business develops biotech and naturally derived actives for skin, hair, and scalp applications. Comparable as a science-led specialty active supplier to personal care brand owners.
• Ashland: Ashland's Life Sciences division supplies specialty proteins, polymers, and bioactive ingredients to personal care and pharmaceutical customers. Comparable in protein/peptide ingredient manufacturing and B2B formulation supply.
• Kermin Industries (Kemin Human Nutrition & Health): Kemin Human Nutrition & Health produces functional bioactive ingredients, including proteins and specialty bioactives, for personal care, nutrition, and animal health customers. Highly comparable to Keraplast's specialty keratin ingredient model serving B2B brand owners.
• Lipotec (Lubrizol Life Science): Lipotec, now part of Lubrizol, is a leader in bioactive peptides and proteins for skin and hair care. Direct competitor in peptide/protein-based cosmetic actives with overlapping claim territory (anti-aging, hair repair).
• Organogenesis: US-listed regenerative medicine company with biomaterial-based wound care and surgical products. Most direct public peer for Keraplast's Replicine/Keramatrix/Keragel/Kerox wound care franchise via BioWound Solutions.
• Mibelle Biochemistry: Swiss developer of biotech-derived active ingredients (plant cell culture, peptides, proteins) sold to cosmetics and personal care formulators. Directly comparable to Keraplast's Functional Keratin platform in technology and B2B go-to-market.
• Lucas Meyer Cosmetics (IFF Health & Biosciences): Lucas Meyer Cosmetics, part of IFF, supplies phospholipids, peptides, and functional actives to personal care formulators. IFF Health is already a Keraplast distribution partner, and Lucas Meyer is a direct peer in specialty cosmetic actives.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/keraplast-manufacturing

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Keraplast Manufacturing